Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Oncotarget
|
July 18, 2020
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer
Takemasa Tsuji, Kevin H Eng, Junko Matsuzaki, et al.
Cancer Immunology Research
|
July 1, 2024
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
Bowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
Cancer Immunology Research
|
February 19, 2014
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer
Kunle Odunsi, Junko Matsuzaki, Smitha R James, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors
Henry G Withers, Junko Matsuzaki, Mark Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2012
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
Paul Sabbatini, Takemasa Tsuji, Luis Ferran, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2019
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Song Liu, Junko Matsuzaki, Lei Wei, et al.
Cancer Research Communications
|
October 23, 2023
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans
Alexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova, et al.
Cell Reports. Medicine
|
September 2, 2025
Zeaxanthin augments CD8<sup>+</sup> effector T cell function and immunotherapy efficacy
Freya Q Zhang, Jiacheng Li, Rukang Zhang, et al.
Science Translational Medicine
|
March 16, 2022
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses
Kunle Odunsi, Feng Qian, Amit A Lugade, et al.
Nature
|
November 22, 2023
Trans-vaccenic acid reprograms CD8<sup>+</sup> T cells and anti-tumour immunity
Hao Fan, Siyuan Xia, Junhong Xiang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Oncotarget
|
July 18, 2020
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer
Takemasa Tsuji, Kevin H Eng, Junko Matsuzaki, et al.
Cancer Immunology Research
|
July 1, 2024
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
Bowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
Cancer Immunology Research
|
February 19, 2014
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer
Kunle Odunsi, Junko Matsuzaki, Smitha R James, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors
Henry G Withers, Junko Matsuzaki, Mark Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2012
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
Paul Sabbatini, Takemasa Tsuji, Luis Ferran, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2019
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Song Liu, Junko Matsuzaki, Lei Wei, et al.
Cancer Research Communications
|
October 23, 2023
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans
Alexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova, et al.
Cell Reports. Medicine
|
September 2, 2025
Zeaxanthin augments CD8<sup>+</sup> effector T cell function and immunotherapy efficacy
Freya Q Zhang, Jiacheng Li, Rukang Zhang, et al.
Science Translational Medicine
|
March 16, 2022
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses
Kunle Odunsi, Feng Qian, Amit A Lugade, et al.
Nature
|
November 22, 2023
Trans-vaccenic acid reprograms CD8<sup>+</sup> T cells and anti-tumour immunity
Hao Fan, Siyuan Xia, Junhong Xiang, et al.
Page
of 6